大量输血中枸橼酸对病理生理的影响
本文为叙述性综述,聚焦大量输血时枸橼酸对生理的影响。健康人可快速清除一单位血中的枸橼酸,但失血性休克时清除下降、循环中枸橼酸延长。低体温和酸血症均降低枸橼酸清除,而循环枸橼酸降低凝血酶生成和血小板功能,导致离子钙降低、凝血障碍和需进一步输血,形成新的枸橼酸负荷。全血输血所需输注产品量通常低于单纯成分输血,枸橼酸负荷更低。作者认为应努力限制失血性休克患者输入的枸橼酸量,同时处理诱导的低钙血症。
要点
- 健康人可快速清除一单位血中的枸橼酸(通过三羧酸循环或尿直接排泄),但失血性休克时清除下降、枸橼酸循环延长。
- 低体温和酸血症均降低枸橼酸清除,循环枸橼酸降低凝血酶生成和血小板功能,导致离子钙降低和凝血障碍。
- 凝血障碍、酸血症、低体温和低钙血症的所谓「死亡菱形」与枸橼酸动态交互,可导致死亡螺旋。
- 全血输血所需输注产品量通常低于单纯成分输血,枸橼酸负荷更低。
- 作者认为应努力限制失血性休克患者输入的枸橼酸量,同时处理诱导的低钙血症。
适用人群与场景
- 大量输血的出血患者
- 失血性休克患者
处置流程与药物剂量
- 作者认为应努力限制失血性休克患者输入的枸橼酸量,同时处理诱导的低钙血症。
红旗征与不能漏的情况
- 凝血障碍、酸血症、低体温和低钙血症的「死亡菱形」与枸橼酸动态交互,可导致死亡螺旋。
研究设计与关键结果
- 本文为叙述性综述,非系统评价或Meta分析,未进行新的统计分析。
- 健康个体可快速清除一单位血中的枸橼酸(通过三羧酸循环或尿直接排泄),但失血性休克生理可导致清除下降和枸橼酸循环延长。
- 低体温和酸血症均降低枸橼酸清除,而循环枸橼酸降低凝血酶生成和血小板功能,导致离子钙降低、凝血障碍和需进一步输血,形成新的枸橼酸负荷。
- 全血输血所需输注产品量通常低于单纯成分输血,枸橼酸负荷更低。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为应努力限制失血性休克患者输入的枸橼酸量,同时处理诱导的低钙血症。
- 全血输血所需输注产品量通常低于单纯成分输血,枸橼酸负荷更低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: This narrative review article seeks to highlight the effects of citrate on physiology during massive transfusion of the bleeding patient.
DATA SOURCES: A limited library of curated articles was created using search terms including "citrate intoxication," "citrate massive transfusion," "citrate pharmacokinetics," "hypocalcemia of trauma," "citrate phosphate dextrose," and "hypocalcemia in massive transfusion." Review articles, as well as prospective and retrospective studies were selected based on their relevance for inclusion in this review.
STUDY SELECTION: Given the limited number of relevant studies, studies were reviewed and included if they were written in English. This is not a systematic review nor a meta-analysis.
DATA EXTRACTION AND SYNTHESIS: As this is not a meta-analysis, new statistical analyses were not performed. Relevant data were summarized in the body of the text.
CONCLUSIONS: The physiologic effects of citrate independent of hypocalcemia are poorly understood. While a healthy individual can rapidly clear the citrate in a unit of blood (either through the citric acid cycle or direct excretion in urine), the physiology of hemorrhagic shock can lead to decreased clearance and prolonged circulation of citrate. The so-called "Diamond of Death" of bleeding-coagulopathy, acidemia, hypothermia, and hypocalcemia-has a dynamic interaction with citrate that can lead to a death spiral. Hypothermia and acidemia both decrease citrate clearance while circulating citrate decreases thrombin generation and platelet function, leading to ionized hypocalcemia, coagulopathy, and need for further transfusion resulting in a new citrate load. Whole blood transfusion typically requires lower volumes of transfused product than component therapy alone, resulting in a lower citrate burden. Efforts should be made to limit the amount of citrate infused into a patient in hemorrhagic shock while simultaneously addressing the induced hypocalcemia.
参考来源
- Schriner JB, Van Gent JM, Meledeo MA, et al. Impact of Transfused Citrate on Pathophysiology in Massive Transfusion. Crit Care Explor. 2023. PMID: 37275654. doi:10.1097/CCE.0000000000000925
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。